Detalhe da pesquisa
1.
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.
Br J Haematol
; 187(1): 93-104, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172513
2.
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
Br J Haematol
; 184(5): 797-807, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548583
3.
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model.
Eur J Haematol
; 2018 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30084111
4.
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.
Br J Haematol
; 173(2): 245-52, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26847165
5.
MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry.
Cell Commun Signal
; 14: 2, 2016 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26754424
6.
Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(10): 1580-5, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24952358
7.
Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.
Br J Haematol
; 164(5): 668-74, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24274082
8.
Advanced Carbon-Based Polymeric Nanocomposites for Forensic Analysis.
Polymers (Basel)
; 14(17)2022 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36080673
9.
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.
Stem Cell Res Ther
; 10(1): 63, 2019 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30795797
10.
Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).
Stem Cell Res Ther
; 9(1): 150, 2018 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848379
11.
HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?
Oncotarget
; 8(17): 28187-28202, 2017 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390197
12.
Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis.
PLoS One
; 12(8): e0182470, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28796790
13.
Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines.
PLoS One
; 9(3): e92378, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658332
14.
Update on the role of autologous hematopoietic stem cell transplantation in follicular lymphoma.
Mediterr J Hematol Infect Dis
; 4(1): e2012074, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23205262